Standard BioTools to Sell Microfluidics Unit to ARCHIMED
Standard BioTools Inc. agreed to sell its Microfluidics business to ARCHIMED. The closing is expected in approximately 30 days, subject to customary conditions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.